Qubit Pharmaceutical
The company develops a molecular modeling and simulation platform called ATLAS that utilizes quantum physics and artificial intelligence to design drug candidates. The platform focuses on oncology, inflammation, and pandemic response by simulating molecular dynamics and binding free energy to optimize drug selection. They partner with biotech and pharmaceutical companies for joint drug discovery programs and out-licensing opportunities.
Visit websiteParis, France
Healthtech
Biotechnology
Pharmaceuticals
Quantum Computing
Artificial Intelligence
Funding summary
- Total raised
- €16.0M
- Funding rounds
- 1
Investors in Qubit Pharmaceutical
Investors on record for Qubit Pharmaceutical. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Qubit Pharmaceutical?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors